AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02429817 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Aeroneb Solo
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Nitrous Oxide/Oxygen
Description: Combination of NO2 \& O2 for anesthesia induction.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: Propofol 1-1.5 mg/kg to facilitate endotracheal intubation.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Propofol
Description: Propofol 1-1.5 mg/kg to facilitate endotracheal intubation.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Morphine
Description: Morphine 0.1 mg/kg given prior to intubation.
Study NCT02429817 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Jet Nebulizer
Study NCT02946944 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: apixaban
Description: After arrival to the emergency department, a series of surveys to determine the risk of death from pulmonary embolism are carried out. Then angiography, tensiometry of SBCC, catheter thrombus fragmentation are scheduled. Then puncture of the right jugular vein is performed. PigTail catheter is inserted via guidewire into the pulmonary artery . Angiography of the pulmonary arteries is performed. Miller index is calculated. Catheter thrombus fragmentation is performed by a PigTail catheter. RV, RA pressures are measured. In the ICU heparin is prescribed (of 1000 units per hour) under the control of PTT (50-75s). The next day patients are randomizaed to assign them into 2 groups.Mono drug therapy is going to be administered to this group (active comparator): apixaban 10 mg 2p \\ d for 14 days. On the 7th day MSCT angiography of the pulmonary aretry with contrast and echocardiogram are performed. On the 14th day the controlechocardiogram is performed .
Study NCT03044678 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: REACH for Success
Description: Exposure-based cognitive behavioral with social skill training (cognitive self control, relaxation, skills for conversations and assertiveness)
Study NCT03044678 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Self-Study
Description: Books for youth about anxiety management
Study NCT03372096 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Prostatic Artery Embolization
Description: LC Bead LUMI is a spherical polyvinyl alcohol embolic particle that incorporates radiopaque moieties. Once a catheter has been fluoroscopically guided into the target vessel, the beads are then injected, causing obstruction at the arteriole level until the desired degree of embolization has occurred.
Study NCT02050191 — intervention group
Intervention type: BEHAVIORAL
Group type: NO_INTERVENTION
Intervention: www.princetonlivingwell.com
Study NCT00040365 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Amifostine trihydrate
Description: 1000 mg for the first 18 patients. 2000 mg for the last 12 patients. The syringe of amifostine will be connected to a rectal enema bottle for administration. Administered slowly over 30-60 seconds with the patient in recumbent position 30-45 minutes prior to each radiation treatment (33-39 doses).
Study NCT00040365 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation therapy
Description: The treatment will be delivered in at least two phases. The first field reduction will occur after 46Gy and the second field reduction will occur after 70Gy.
Study NCT01134276 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: biliary drainage
Description: biliary drainage via PTBD or ERBD/ENBD
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Morphine
Description: Morphine 0.1 mg/kg given prior to intubation.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ondansetron
Description: Ondansetron (0.15 mg/kg, maximum dose of 4 mg) for postoperative nausea prophylaxis.
Study NCT02880397 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Garcinia mangostana
Description: The properties of mangostana includes antibacterial, antifungal, anti-inflammatory, anti-microbial, antioxidant, anticancer, anti-proliferative, pro-apoptotic, aromatase inhibitory properties
Study NCT02429817 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Single photon emission computed tomography
Description: Imaging technique to investigate lung aerosol distribution
Study NCT02880397 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo gel
Description: The properties of placebo includes antibacterial, antifungal, anti-inflammatory, anti-microbial, antioxidant, anticancer, anti-proliferative, pro-apoptotic, aromatase inhibitory properties
Study NCT02655445 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mini-craniotomy
Description: chronic subdural hematoma evacuation through minicraniotomy
Study NCT02655445 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Twist Drill Craniostomy
Description: chronic subdural hematoma evacuation through twist drill craniostomy
Study NCT02655445 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Burr Hole Craniostomy
Description: chronic subdural hematoma evacuation through burr holes
Study NCT05476198 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Brachial plexus block
Description: The effect of brachial plexus block method on preoperative anxiety levels in patients who will undergo orthopedic upper extremity surgery.
Study NCT05476198 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: General anesthesia
Description: The effect of general anesthesia method on preoperative anxiety levels in patients who will undergo orthopedic upper extremity surgery.
Study NCT01167582 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Red blood cell transfusion
Description: Liberal versus restrictive transfusion
Study NCT03347136 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: CPAP
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Ondansetron
Description: Ondansetron (0.15 mg/kg, maximum dose of 4 mg) for postoperative nausea prophylaxis.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone
Description: Dexamethasone (0.25 mg/kg, maximum dose of 20 mg) for postoperative nausea prophylaxis.
Study NCT02429817 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Spirometry
Description: FEV1, FVC assessment
Study NCT04823767 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Single anastomosis sleeve jejunal bypass with hiatal repair
Description: Single anastomosis sleeve jejunal bypass with hiatal repair
Study NCT03347136 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIPPV
Study NCT03916523 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sustained lung inflation
Description: Preterm infants will receive a total of 15 sustained lung inflations during the first 4 days of life as follows:~1. On day 1 of life (a total of 6 sustained lung inflations, 20 cmH2O for 21 seconds each) once at enrollment and then once every 4 hours~2. On day 2 of life (a total of 3 sustained lung inflations, 15 cmH2O for 21 seconds each) once every 8 hours.~3. On day 3 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.~4. On day 4 of life (a total of 3 sustained lung inflations 10cmH2O for 21 seconds each) once every 8 hours.
Study NCT03916523 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Continuous positive airway pressure (CPAP)
Description: Preterm infants will receive CPAP for respiratory support.
Study NCT02695654 — intervention group
Intervention type: DRUG
Intervention: Levobupivacaine
Description: 14 ml of 0,25 % Levobupivacaine
Study NCT02695654 — intervention group
Intervention type: DRUG
Intervention: Clonidine
Description: Clonidine 100 mcg
Study NCT03005392 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: exercise
Description: An exercise program will be designed over 16 weeks with 55 sessions, moderately increasing the volume and intensity of the load every 4 weeks. The program will consist of strength exercises, flexibility and aerobic endurance, which will be explained in videos and are going to be available in an online platform.~The physiotherapist will contact the patient and/or tutor weekly so as to answer and doubts they may have with respect to the exercise program and to further supervise their compliance (group with intervention).
Study NCT03386331 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: diet and exercise
Description: Diet and lifestyle intervention
Study NCT00061919 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin, etoposide & thalidomide
Description: Carboplatin IV on day 1 and etoposide IV on day 1 and 2 and, orally Day 3. Oral thalidomide daily beginning on day 1 for up to 24 months.
Study NCT00764283 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Tegaderm dressing
Description: Tegaderm dressing is used to secure the epidural catheter for postoperative analgesia
Study NCT00764283 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Epi-Fix dressing
Description: Epi-Fix dressing is used to secure the epidural catheter for postoperative analgesia
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: blood sample
Description: 25 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: blood sample
Description: 25 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: urine sample
Description: 10 ml
Study NCT00061919 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Carboplatin, etoposide & placebo
Description: Carboplatin IV on day 1 and etoposide IV on day 1 and 2 and, orally Day 3. Oral placebo daily beginning on day 1 for up to 24 months.
Study NCT03916523 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Mechanical ventilation
Description: Preterm infants in this group will receive mechanical ventilation for respiratory support
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: urine sample
Description: 10 ml
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: food questionnaire
Description: dietary habit enquiry and a 48h dietary
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: food questionnaire
Description: dietary habit enquiry and a 48h dietary
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: hair
Description: lock of hair
Study NCT03421184 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hair
Description: lock of hair
Study NCT03398746 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: LOOP Technique
Description: Placement of subcutaneous loop drain
Study NCT03398746 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Standard incision and drainage
Description: Incise and drain with placement of packing
Study NCT04262401 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard health coaching
Description: 12 weekly sessions of standard health coaching followed by 4 monthly sessions
Study NCT04262401 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Habit-focused health coaching
Description: 12 weekly sessions of standard health coaching followed by 4 monthly sessions
Study NCT02168803 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evacetrapib
Description: Administered orally
Study NCT01290445 — intervention group
Intervention type: DRUG
Intervention: varenicline
Description: This is a non-interventional study. Exposure in utero to varenicline is observed, not assigned.
Study NCT01290445 — intervention group
Intervention type: BEHAVIORAL
Intervention: cigarette smoke from maternal smoking
Description: This is a non-interventional study. Exposure in utero to cigarette smoke from maternal smoking is observed, not assigned.
Study NCT00764283 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Lockit-Plus
Description: Lockit-Plus dressing is used to secure the epidural catheter for postoperative analgesia
Study NCT01290445 — intervention group
Intervention type: OTHER
Intervention: Non-Exposure
Description: This is a non-interventional study. Non-exposure in utero to varenicline and cigarette smoke from maternal smoking is observed, not assigned.
Study NCT00674518 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: One on one counseling
Description: Motivational Interviewing
Study NCT00674518 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Group/team - based health education
Description: peer led, scripted health promotion curriculum in groups of 4-5 individual, with team building activities and health education for 12, 1-hour sessions per year.
Study NCT00674518 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: PACE physician counseling
Description: PACE format for physician exercise and nutrition counseling annually.
Study NCT01690754 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Interactive Reminders
Description: Daily SMS reminders sent to TB patients at a pre-specified time. They are asked to respond to the reminders. If a response is not received within two hours, they are sent another reminder for up to three per day.
Study NCT03564886 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hyperosmolar Saline
Description: The hyperosmolar solution will be created by adding 120cc of 23.4% NS solution to a 3L bag of LR.
Study NCT03564886 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Lactate Ringer's (LR, 273mOsm/L)
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac
Description: Orally 100 mg Diclofenac, administered 1 hour before surgery
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: 5 mg Dormicum intramuscularly, administered 1 hour before surgery
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atropine
Description: 0.5 mg Atropine intramuscularly, administered 1 hour before surgery
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: bucain + fentanyl
Description: Via the thocacic epidural cannula 1mg/ml bucain + 5microgr/ml fentanyl solution, with 0.1ml/kg body mass/hour speed is administered.
Study NCT01691690 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Dexamethasone
Description: Dexamethasone (0.25 mg/kg, maximum dose of 20 mg) for postoperative nausea prophylaxis.
Study NCT00253110 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: risperidone
Study NCT00253110 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: haloperidol
Study NCT01708798 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Eplerenone
Study NCT01708798 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03070678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sotagliflozin (SAR439954)
Description: Pharmaceutical form: tablet~Route of administration: oral
Study NCT03070678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Description: Pharmaceutical form: capsule~Route of administration: oral
Study NCT03319797 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: NOVOCART® Inject plus
Description: Treatment with NOVOCART® Inject plus (Autologous chondrocyte implantation)
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nalbuphine
Description: 1st choice for rescue analgetic 10-20 mg intravenously
Study NCT01071460 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: FlexStent Femoropopliteal Self-Expanding Stent System
Description: Peri-procedural management will be no different to routine SFA/Popliteal Artery intervention Standard medical therapy~Procedural techniques will be identical to routine protocols for SFA/Popliteal Artery stenting. technique suggested:~* Contralateral retrograde common femoral cross-over access or antegrade access~* Target lower limb arteries fully imaged angiogram. with measurement of SFA/Popliteal Artery target lesion length and normal vessel diameter immediately above and below target lesion~* Pre-stenting balloon dilatation of target lesion in all total occlusions and critical stenosis~* Deployment of an appropriately sized FlexStent® to cover target lesion~* Post-stent balloon dilate stent using a semi-compliant angioplasty balloon to enable accurate post-dilatation of stent to target diameter~* Post stenting angiography assessing target lesion parameters, run-off vessel patency and complications
Study NCT03023800 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Macular buckling
Description: Surgical procedures of macular buckling, drainage of aqueous fluid (0.1-0.2 ml) through limbal paracentesis, and inject gas ( C3F8 100%, 0.2ml-0.3ml) into vitreous body through pars plana, under systemic anesthesia.
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diclofenac
Description: 2nd choice for rescue analgetic 250ml intravenously
Study NCT03324321 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Hypocapnia via Hyperventilation Protocol
Description: 90 seconds of hyperventilation using a metronome to lower levels of -5mmHg and -10mmHg below baseline EtCO2
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metamizole-sodium
Description: Additional rescue analgetic 2g intravenously
Study NCT02445599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tramadol
Description: Additional rescue analgetic 100mg intravenously
Study NCT00607971 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Renzapride
Description: All subjects take two capsules (2x renzapride 2 mg) daily, from the day of enrolment until the scheduled visit at the end of Week 52
Study NCT02692170 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CVI-HBV-001
Description: Investigational Product
Study NCT01093131 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Oral hydration
Description: Oral hydration with 500 mL of water to be started 4 hours prior to contrast exposure and stopped 2 hours prior to procedure followed by oral hydration with 600 mL of water post procedure
Study NCT01093131 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Oral sodium bicarbonate
Description: Oral hydration with 500 mL of water to be started 4 hours prior to procedure and stopped 2 hours prior to contrast exposure, with the addition of 3.9 grams (46.4 mEq) of oral sodium bicarbonate to be given 20 minutes prior to contrast exposure followed by 1.95 grams (30.4 mEq) of oral sodium bicarbonate 2 hours and 4 hours after the initial dose
Study NCT01093131 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous Hydration
Description: Pretreatment with a 3 mL/kg bolus of intravenous normal saline solution (154 mEq/L) over 1 hour, immediately prior to contrast exposure followed by intravenous infusion of 1ml/kg per for 6 hours after the procedure.
Study NCT01093131 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Intravenous sodium bicarbonate
Description: Pretreatment with a 3 mL/kg bolus of intravenous sodium bicarbonate solution (154 mEq/L) over 1 hour, immediately prior to contrast exposure followed by intravenous infusion of 1 mL/kg for 6 hours after the procedure.
Study NCT03946969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sintilimab
Description: Sintilimab (200mg) will be given intravenously on day 1 in 3-week cycles for two cycles.
Study NCT03946969 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Liposomal Paclitaxel + Cisplatin + S-1
Description: Liposomal Paclitaxel (135mg/m2), ivd, d1 + Cisplatin (25mg/m2), ivd, d1-3 + S-1 capsule (40mg), po, d1-14, repeated every 3 weeks for two cycles.
Study NCT02546362 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Cefaly
Study NCT03023800 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Vitrectomy
Description: Surgical procedures of small gauge vitrectomy, internal limiting membrane peeling, and gas (C3F8, 14%) tamponage, under local or systemic anesthesia
Study NCT04277221 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Autologous Dendritic Cell/Tumor Antigen, ADCTA
Description: ADCTA is an individualized cell immunotherapy co-culturing autologous dendritic cells derived from peripheral blood mononuclear cells (PBMNCs) with autologous tumor cell as antigen in order to evoke specific immune response.
Study NCT04277221 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Autologous Dendritic Cell/Tumor Antigen, ADCTA
Description: ADCTA is an individualized cell immunotherapy co-culturing autologous dendritic cells derived from peripheral blood mononuclear cells (PBMNCs) with autologous tumor cell as antigen in order to evoke specific immune response.
Study NCT02772471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: HS-1000
Study NCT02877017 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Family safety reporting intervention
Description: family safety reporting intervention for families and providers
Study NCT01727934 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Miravirsen sodium
Description: Subcutaneous injection